741 Safety Profile of Keytruda (pembrolizumab) for the treatment of patients with advanced PD-L1 positive cervical cancer | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Cervical cancer

741 Safety Profile of Keytruda (pembrolizumab) for the treatment of patients with advanced PD-L1 positive cervical cancer

Free

Online download statistics by month:

Online download statistics by month: October 2021 to March 2023

	Abstract	Full	Pdf
Oct 2021	70	0	13
Nov 2021	63	0	10
Dec 2021	25	0	7
Jan 2022	78	0	12
Feb 2022	30	0	6
Mar 2022	28	0	11
Apr 2022	13	0	10
May 2022	33	0	11
Jun 2022	16	0	9
Jul 2022	40	0	6
Aug 2022	21	0	4
Sep 2022	31	0	6
Oct 2022	36	0	7
Nov 2022	25	0	7
Dec 2022	26	0	7
Jan 2023	24	0	6
Feb 2023	22	0	0
Mar 2023	20	0	3
Total	601	0	135